Due to increasing regulatory requirements, the need for quality study and patient safety data is critical as we work together to bring our clients’ novel treatments to patients. PRA Health Sciences is diligently working to meet our clients’ data demands through the substantial growth of our Data Monitoring Committee (DMC) services over recent years. Staffed by a global team of experts, PRA’s dedicated DMC Unit ensures our clients’ projects meet the most stringent regulatory requirements.
Explore related content and topics
Blog
Fighting Mesothelioma
Newsletter
Industry Watch
With fall in the air in the northern hemisphere, it’s also a week full of noteworthy news in clinical development. New research shines a light on…
Newsletter
Industry Watch
We wrap up the final week of August with news of exciting scientific advancements that have the potential to help develop therapies to prevent…